|
MMADHC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.65632002242E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.60170004931604E-09 |
| Normal-vs-Stage2 |
1.82489999778213E-08 |
| Normal-vs-Stage3 |
9.54769596717142E-11 |
| Normal-vs-Stage4 |
7.32802707403835E-12 |
| Stage1-vs-Stage2 |
5.399700E-02 |
| Stage1-vs-Stage3 |
5.779900E-02 |
| Stage1-vs-Stage4 |
2.899100E-03 |
| Stage2-vs-Stage3 |
6.220800E-01 |
| Stage2-vs-Stage4 |
6.712800E-01 |
| Stage3-vs-Stage4 |
2.830400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.56745793700975E-12 |
| Normal-vs-AfricanAmerican |
6.4314999999926E-05 |
| Normal-vs-Asian |
9.51299999996102E-07 |
| Caucasian-vs-AfricanAmerican |
6.910600E-01 |
| Caucasian-vs-Asian |
7.011600E-01 |
| AfricanAmerican-vs-Asian |
9.235800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.7069012869797E-11 |
| Normal-vs-Female |
1.12699960475027E-10 |
| Male-vs-Female |
1.936960E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.00700000005283E-07 |
| Normal-vs-Age(41-60Yrs) |
9.68169988624368E-12 |
| Normal-vs-Age(61-80Yrs) |
5.15765208319863E-12 |
| Normal-vs-Age(81-100Yrs) |
1.176260E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.025800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.442600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.572000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.905370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.340600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.784200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.384400E-01 |
| Classical-VS-Follicular |
2.658300E-02 |
| Classical-VS-Other |
3.598400E-01 |
| Classical-VS-Normal |
1.28480004413234E-10 |
| Tall-VS-Follicular |
2.489400E-01 |
| Tall-VS-Other |
5.661000E-01 |
| Tall-VS-Normal |
1.60204999999358E-05 |
| Follicular-VS-Other |
9.744800E-01 |
| Follicular-VS-Normal |
7.57550022711939E-10 |
| Other-VS-Normal |
2.658200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.71840344573593E-11 |
| Normal-vs-N1 |
1.86130000301432E-10 |
| N0-vs-N1 |
1.291650E-01 |
|
|
